The CD33 expression level appears linked to the differentiation status of the leukemia clone (e.g., high level is seen in acute promyelocytic leukemia; APL), the cytogenic profiles and to certain mutations, such as NPM1 and FLT3/ITD [4]. This evidence concerns the gene FLT3 and acute promyelocytic leukemia.